Clinical Trial Update: B.Subtilis Attenuate Symptoms in Diarrhea-predominant Irritable Bowel Syndrome by Increasing Hypoxanthine Biosynthesis [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) trial evaluating Bacillus subtilis (B.Subtilis) to relieve symptoms of diarrhea-predominant irritable bowel syndrome by boosting hypoxa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Diarrhea
• Purine Metabolism Disorder

Drugs mentioned

• B.Subtilis (Bacillus subtilis)

Snippet

Sponsor: Jinling Hospital, China | Conditions: Irritable Bowel Syndrome with Diarrhea, Purine Metabolism Disorder | EARLY_Phase 1 | Status: RECRUITING